Pharma Journalist -

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to delay the progression of renal…
Read More...

The U.S. Food and Drug Administration approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD)…
Read More...

The WIRB-Copernicus Group's (WCG) Clinical Services Division introduces Velos eResearch eXpress, an out-of-the-box, cloud-based solution that enables clinical research sites to…
Read More...

Mustang Bio, Inc. announced that it has entered into a license agreement with CSL Behring for the Cytegrity stable producer cell line developed and used by St. Jude Children’s Research…
Read More...

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and Freenome, a biotechnology company that…
Read More...

Johnson & Johnson and its Janssen Pharmaceutical Companies announced they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State of…
Read More...

Zogenix, Inc. announced that it has entered into a definitive agreement to acquire Modis Therapeutics, Inc., a privately held biopharmaceutical company focused on developing novel…
Read More...

SMi Group reports: Principal Scientist from Sanofi R&D is set to present at SMi’s 5th Annual Lyophilization 2 Day Conference taking place in Boston on October 23 – 24, 2019. This…
Read More...

SMi Reports: SMi presents workshops for the upcoming Biobanking conference this September with industry experts Laurent Dolle, Managing Director, BWB and Mary-beth Joshi, Director,…
Read More...

GlaxoSmithKline plc announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare seeking marketing approval for daprodustat, an oral…
Read More...